{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:42:54Z","timestamp":1786164174859,"version":"build-2736575974"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7614-26","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T22:10:07Z","timestamp":1786140607000},"source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Hypertension with a High-Output Hemodynamic Profile in a Child with MELAS: A Case Report"],"prefix":"10.2169","author":[{"given":"Miki","family":"Kanai","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Saiseikai Niigata Kenoh Kikan Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tsuru","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Onuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Nukaga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehito","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tsukada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaaki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujito","family":"Numano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Juntendo University, Japan"},{"name":"Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niigata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Goto Y, Nonaka I, Horai S. A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348: 651-653, 1990.","DOI":"10.1038\/348651a0"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42: 545-550, 1992.","DOI":"10.1212\/WNL.42.3.545"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Na JH, Lee YM. Diagnosis and management of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. Biomolecules 14: 1524, 2024.","DOI":"10.3390\/biom14121524"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yatsuga S, Povalko N, Nishioka J, et al. MELAS: A nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 1820: 619-624, 2012.","DOI":"10.1016\/j.bbagen.2011.03.015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 116: 4-12, 2015.","DOI":"10.1016\/j.ymgme.2015.06.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brambilla A, Favilli S, Olivotto I, et al. Clinical profile and outcome of cardiac involvement in MELAS syndrome. Int J Cardiol 276: 14-19, 2019.","DOI":"10.1016\/j.ijcard.2018.10.051"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Majamaa-Voltti K, Peuhkurinen K, Kortelainen ML, Hassinen IE, Majamaa K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord 2: 12, 2002.","DOI":"10.1186\/1471-2261-2-12"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hung PC, Wang HS, Chung HT, Hwang MS, Ro LS. Pulmonary hypertension in a child with mitochondrial A3243G point mutation. Brain Dev 34: 866-868, 2012.","DOI":"10.1016\/j.braindev.2012.02.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sproule DM, Dyme J, Coku J, et al. Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA ((Leu) ) gene (m.3243A>G). J Inherit Metab Dis 31 (Supplement 3): 497-503, 2008.","DOI":"10.1007\/s10545-007-0735-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Preston G, Jacob N, Elsharkawi I, Morava E, Kozicz T. Phosphodiesterase type 5 inhibition as a therapeutic strategy in primary mitochondrial disease: Evidence from patient fibroblasts and clinical observations. Mol Genet Metab 146: 109197, 2025.","DOI":"10.1016\/j.ymgme.2025.109197"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mukherjee D, Konduri GG. Pediatric pulmonary hypertension: definitions, mechanisms, diagnosis, and treatment. Compr Physiol 11: 2135-2190, 2021.","DOI":"10.1002\/j.2040-4603.2021.tb00176.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant 38: 879-901, 2019.","DOI":"10.1016\/j.healun.2019.06.022"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sullivan RT, Austin ED. Pulmonary hypertension in children. Clin Chest Med 45: 685-693, 2024.","DOI":"10.1016\/j.ccm.2024.04.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Qaiser KN, Sahay S, Tonelli AR. Pulmonary hypertension due to high cardiac output. Respir Med 206: 107034, 2023.","DOI":"10.1016\/j.rmed.2022.107034"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang W, Liu B, Wang Y, et al. Mitochondrial dysfunction in pulmonary arterial hypertension. Front Physiol 13: 1079989, 2022.","DOI":"10.3389\/fphys.2022.1079989"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Santos EW, Khatoon S, Di Mise A, Zheng YM, Wang YX. Mitochondrial dynamics in pulmonary hypertension. Biomedicines 12: 53, 2023.","DOI":"10.3390\/biomedicines12010053"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Li H, Dai X, Zhou J, et al. Mitochondrial dynamics in pulmonary disease: implications for the potential therapeutics. J Cell Physiol 239: e31370, 2024.","DOI":"10.1002\/jcp.31370"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lee SR, Kim N, Noh YH, et al. Mitochondrial DNA, mitochondrial dysfunction, and cardiac manifestations. Front Biosci (Landmark Ed) 22: 1177-1194, 2017.","DOI":"10.2741\/4541"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakagawa H, Okayama S, Kamon D, et al. Refractory high output heart failure in a patient with primary mitochondrial respiratory chain disease. Intern Med 53: 315-319, 2014.","DOI":"10.2169\/internalmedicine.53.1386"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Clifford PS, Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol (1985) 97: 393-403, 2004.","DOI":"10.1152\/japplphysiol.00179.2004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Peng HL, Ivarsen A, Nilsson H, Aalkjaer C. On the cellular mechanism for the effect of acidosis on vascular tone. Acta Physiol Scand 164: 517-525, 1998.","DOI":"10.1111\/j.1365-201X.1998.tb10701.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Finsterer J. Pancreatitis as a manifestation of mitochondrial disorder. Am J Med Genet A 14A3: 632-633, 2007.","DOI":"10.1002\/ajmg.a.31629"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kandoi K, Gan S, Gamboa D, et al. High-output cardiac failure in the setting of iron deficiency anaemia: a case report. Cardiol Young 34: 1823-1824, 2024.","DOI":"10.1017\/S1047951124025277"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nakano K, Yamamoto M, Yamada Y, et al. Mitochondrial structural abnormalities and cardiac reverse remodeling in patients with systolic dysfunction. Circ J 89: 101-108, 2025.","DOI":"10.1253\/circj.CJ-24-0451"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7614-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:06:29Z","timestamp":1786161989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7614-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7614-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7614-26"}}